US 10,376,491 B2
Pharmaceutical composition containing silibinin and pueraria root extract
Xijun Yan, Tianjin (CN); Naifeng Wu, Tianjin (CN); He Sun, Tianjin (CN); Kaijing Yan, Tianjin (CN); Yonghong Zhu, Tianjin (CN); Xiaohui Ma, Tianjin (CN); Shunnan Zhang, Tianjin (CN); Changwen Li, Tianjin (CN); Xiaolin Bai, Tianjin (CN); Ting Li, Tianjin (CN); Lei Li, Tianjin (CN); and Yi He, Tianjin (CN)
Assigned to Tasly Pharmaceutical Group Co., Ltd., Tianjin (CN)
Appl. No. 15/560,583
Filed by TASLY PHARMACEUTICAL GROUP CO., LTD., Tianjin (CN)
PCT Filed Mar. 22, 2016, PCT No. PCT/CN2016/077038
§ 371(c)(1), (2) Date Sep. 22, 2017,
PCT Pub. No. WO2016/150379, PCT Pub. Date Sep. 29, 2016.
Claims priority of application No. 2015 1 0128638 (CN), filed on Mar. 23, 2015.
Prior Publication US 2018/0104216 A1, Apr. 19, 2018
Int. Cl. A61K 36/00 (2006.01); A61K 31/357 (2006.01); A61K 36/82 (2006.01); A61K 47/24 (2006.01); A61K 9/48 (2006.01); A61K 31/205 (2006.01); A61P 1/16 (2006.01); A61K 9/16 (2006.01); A61K 31/355 (2006.01); A61K 31/683 (2006.01); A61K 9/08 (2006.01); A61K 36/488 (2006.01)
CPC A61K 31/357 (2013.01) [A61K 9/08 (2013.01); A61K 9/1617 (2013.01); A61K 9/1682 (2013.01); A61K 9/48 (2013.01); A61K 31/205 (2013.01); A61K 31/355 (2013.01); A61K 31/683 (2013.01); A61K 36/488 (2013.01); A61K 36/82 (2013.01); A61K 47/24 (2013.01); A61P 1/16 (2018.01); A61K 2236/19 (2013.01)] 20 Claims
 
1. A pharmaceutical composition comprising
8.75-60 parts by weight of silibinin;
15-65 parts by weight of phospholipid;
25-200 parts by weight of Pu'er tea extract; and
5-50 parts by weight of radix puerariae extract.